BT selling $183 million stake in Tech Mahindra
MUMBAI (Reuters) - BT (BT.L) is selling its 9.1 percent stake in Tech Mahindra (TEML.NS) in a deal expected to raise about $183 million and see the British telecoms operator exit an Indian IT services group it co-founded more than two decades ago.
The Tech Mahindra shares are being sold at a floor price of 855 rupees, according to a term sheet seen by Reuters, a discount of 2.8 percent from Tuesday's 879.50 rupees closing price. The stock is up about 53 percent this year.
BT, which set up technology outsourcing services provider Tech Mahindra with India's Mahindra & Mahindra Ltd (MAHM.NS) in 1986 and was its second largest shareholder in the past, has been gradually paring its stake in the Indian joint venture.
It sold 14.1 percent of Tech Mahindra stake for about $250 million in August.
Britain's biggest fixed-line telecoms company is also one of the major clients of Tech Mahindra, which provides technology services to global telecoms operators, and its exit is likely to cloud the outlook for future contracts from BT.
JPMorgan (JPM.N) and Credit Suisse (CSGN.VX) are advising BT on the share sale, and the shares will change hands on the Indian stock exchanges via block deals on Wednesday morning, the term sheet showed.
BT had to rely on deep cost cuts to maintain its full-year earnings outlook after an adverse regulatory ruling and weak European corporate demand sent revenues down 9 percent in the second quarter.
BT's stake sale in Tech Mahindra adds to a busy week for equity offerings in Asia's third-largest economy, with more than $2 billion worth of share deals likely to be closed by Friday, after a lacklustre first half of the year.
The government's sale of a $1.1 billion stake in miner NMDC Ltd (NMDC.NS) is set for Wednesday, while leading telecoms tower operator Bharti Infratel is selling shares to raise up to $830 million in the country's biggest IPO in two years.
(Additional reporting by Indulal P.M. and Abhishek Vishnoi; editing by Dan Lalor and Keiron Henderson)
- Tweet this
- Share this
- Digg this
- UPDATE 2-Malaysia Airlines loses contact with plane carrying 239 people
- UPDATE 3-U.S. FDA probes cognitive impact of new cholesterol drugs
- Malaysia Airlines loses contact with plane carrying 239 people
- UPDATE 3-Boeing reports wing cracks on 787 Dreamliners in production
- No signal picked up from missing Malaysia Airlines plane - Vietnam official
Drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, U.S. regulators said. Full Article